TrialBone marrow transplantation2015

Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing's sarcoma patients.

P Schlegel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.